• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Rep . COVID-19 was associated with the complications after allogeneic hematopoietic stem cell transplantation

tetano

Editor, Senior Moderator
Sci Rep


. 2024 May 23;14(1):11778.
doi: 10.1038/s41598-024-62731-7. COVID-19 was associated with the complications after allogeneic hematopoietic stem cell transplantation

Qi Wen[SUP] #[/SUP][SUP] 1 [/SUP], Ze Guo[SUP] #[/SUP][SUP] 1 [/SUP], Xiao-Hui Zhang[SUP] 1 [/SUP], Lan-Ping Xu[SUP] 1 [/SUP], Yu Wang[SUP] 1 [/SUP], Chen-Hua Yan[SUP] 1 [/SUP], Huan Chen[SUP] 1 [/SUP], Yu-Hong Chen[SUP] 1 [/SUP], Wei Han[SUP] 1 [/SUP], Feng-Rong Wang[SUP] 1 [/SUP], Yu-Qian Sun[SUP] 1 [/SUP], Xiao-Jun Huang[SUP] 1 2 [/SUP], Xiao-Dong Mo[SUP] 3 4 [/SUP]



Affiliations
Abstract

We aimed to identify the severity and duration of COVID-19 infection on complications after allo-HSCT. Enrolled 179 hospitalized patients with COVID-19 were categorized into long-term infection (> 18 days, n = 90) or short-term infection group (≤ 18 days, n = 89) according to the median duration of COVID-19. The severity of COVID-19 was categorized as asymptomatic infection, mild, moderate, severe, and critical illness according to guidelines of National Institutes of Health. Particularly, severe illness and critical illness were classified as serious infection. Asymptomatic infection, mild illness and moderate illness were classified as non-serious infection. The 150-day probabilities of poor graft function (PGF), cytomegalovirus (CMV) pneumonia and non-relapse mortality (NRM) were significantly higher in long-term infection group. The 150-day probabilities of CMV pneumonia and NRM after COVID-19 were higher in serious infection group. The 150-day probabilities of overall survival (OS) was significantly lower in long-term and serious infection group. In multivariable analysis, the severity of COVID-19 was associated with NRM and OS, and the duration of COVID-19 was associated with PGF. In summary, our data reported that the severity and duration of COVID-19 were associated with several complications and contribute to poor outcomes after allo-HSCT.


 
Back
Top Bottom